Location History:
- Livry-Gargan, FR (1984 - 1997)
- Livery-Gargan, FR (1997)
- Meaux, FR (1999)
- Château-Thierry, FR (2012)
- Chateau Thierry, FR (1999 - 2017)
Company Filing History:
6 out of 854 
4 out of 236 
1 out of 26 Years Active: 1984-2017
Title: The Innovative Contributions of Alain Bonnet
Introduction
Alain Bonnet is a notable inventor based in Chateau-Thierry, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel crystalline forms of compounds used in antibacterial treatments. With a total of 16 patents to his name, Bonnet's work has had a considerable impact on medical science.
Latest Patents
Bonnet's latest patents focus on the crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt, commonly referred to as NXL-104. These inventions describe novel crystalline forms of this sodium salt and compositions that include it, either alone or in combination with antibacterial agents such as ceftaroline fosamil. The patents also detail processes for preparing these crystalline forms and methods for treating bacterial infections using them.
Career Highlights
Throughout his career, Alain Bonnet has worked with various companies, including Roussel Uclaf. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health challenges. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Bonnet has collaborated with several professionals in his career, including Alain Priour and Mahendra G Dedhiya. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Alain Bonnet's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to influence the development of effective treatments for bacterial infections.